Ultralife Corporation Logo

Ultralife Corporation

ULBI

(2.2)
Stock Price

7,29 USD

8.55% ROA

6.89% ROE

15.06x PER

Market Cap.

152.103.195,00 USD

9.76% DER

0% Yield

5.44% NPM

Ultralife Corporation Stock Analysis

Ultralife Corporation Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Ultralife Corporation Fundamental Stock Analysis
# Analysis Rating
1 PBV

The stock's low PBV ratio (0.99x) suggests it's undervalued, making it an attractive opportunity for investors.

2 DER

The stock has a minimal amount of debt (21%) relative to its ownership, showcasing a strong financial position and lower risk for investors.

3 ROE

ROE in an average range (3.47%) suggests satisfactory profitability and decent utilization of shareholders' equity.

4 ROA

The stock's ROA (3.33%) indicates that it's doing well in making money from the things it owns. This makes it a good option to invest and make consistent profits.

5 Revenue Growth

Company's revenue has experienced consistent growth over the last three years, indicating a favorable financial trajectory and making it an attractive investment choice.

6 Net Profit Growth

Throughout the last three years, this company has experienced consistent net profit growth, reflecting a robust financial performance and making it an attractive investment prospect.

7 Assets Growth

This company's revenue has shown remarkable growth over the past three years, making it an excellent choice for seeking a consistently prosperous investment.

8 Graham Number

The Graham number analysis indicates that this company's stock price is likely overpriced, raising concerns about its investment potential.

9 Dividend Growth

Potential investors should be aware that the company's dividend growth has shown no upward trend in the past three years, indicating limited potential for increased returns.

10 Dividend

Investors should note the absence of dividends from the company in the last three years, indicating potential financial challenges.

11 Buffet Intrinsic Value

The company's stock presents a potential concern as it appears overvalued (-2.816) by Warren Buffett's formula, indicating that its market price exceeds its estimated intrinsic value.

Ultralife Corporation Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Ultralife Corporation Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Buy
3 RSI Hold
4 Stoch RSI Sell

Ultralife Corporation Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Ultralife Corporation Revenue
Year Revenue Growth
1992 1.500.000
1993 3.900.000 61.54%
1994 5.300.000 26.42%
1995 14.600.000 63.7%
1996 15.100.000 3.31%
1997 15.900.000 5.03%
1998 16.400.000 3.05%
1999 21.100.000 22.27%
2000 24.514.000 13.93%
2001 24.163.000 -1.45%
2002 32.515.000 25.69%
2003 79.450.000 59.07%
2004 98.182.000 19.08%
2005 70.501.000 -39.26%
2006 93.546.000 24.63%
2007 137.596.000 32.01%
2008 254.700.000 45.98%
2009 172.109.000 -47.99%
2010 178.577.000 3.62%
2011 139.386.000 -28.12%
2012 101.657.000 -37.11%
2013 78.835.000 -28.95%
2014 66.494.000 -18.56%
2015 76.427.000 13%
2016 82.460.000 7.32%
2017 85.531.000 3.59%
2018 87.190.000 1.9%
2019 106.795.000 18.36%
2020 107.712.000 0.85%
2021 98.267.000 -9.61%
2022 131.840.000 25.46%
2023 157.952.000 16.53%
2023 158.644.000 0.44%
2024 171.932.000 7.73%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Ultralife Corporation Research and Development Expenses
Year Research and Development Expenses Growth
1992 0
1993 0 0%
1994 0 0%
1995 0 0%
1996 0 0%
1997 3.900.000 100%
1998 6.700.000 41.79%
1999 5.900.000 -13.56%
2000 5.306.000 -11.19%
2001 3.424.000 -54.96%
2002 4.291.000 20.21%
2003 2.505.000 -71.3%
2004 2.633.000 4.86%
2005 3.751.000 29.81%
2006 5.097.000 26.41%
2007 7.000.000 27.19%
2008 8.138.000 13.98%
2009 9.540.000 14.7%
2010 8.817.000 -8.2%
2011 8.595.000 -2.58%
2012 7.216.000 -19.11%
2013 5.859.000 -23.16%
2014 5.333.000 -9.86%
2015 5.603.000 4.82%
2016 5.946.000 5.77%
2017 4.737.000 -25.52%
2018 4.508.000 -5.08%
2019 6.805.000 33.75%
2020 5.947.000 -14.43%
2021 6.826.000 12.88%
2022 7.081.000 3.6%
2023 7.476.000 5.28%
2023 7.434.000 -0.56%
2024 7.180.000 -3.54%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Ultralife Corporation General and Administrative Expenses
Year General and Administrative Expenses Growth
1992 0
1993 0 0%
1994 0 0%
1995 0 0%
1996 0 0%
1997 0 0%
1998 0 0%
1999 0 0%
2000 0 0%
2001 0 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 21.090.000 100%
2013 17.272.000 -22.11%
2014 15.417.000 -12.03%
2015 14.174.000 -8.77%
2016 15.367.000 7.76%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2023 0 0%
2024 0 0%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Ultralife Corporation EBITDA
Year EBITDA Growth
1992 -2.300.000
1993 -1.800.000 -27.78%
1994 -4.500.000 60%
1995 -6.300.000 28.57%
1996 -9.600.000 34.38%
1997 -7.700.000 -24.68%
1998 -12.700.000 39.37%
1999 -9.400.000 -35.11%
2000 -14.189.000 33.75%
2001 -8.693.000 -63.22%
2002 -6.948.000 -25.12%
2003 8.022.000 186.61%
2004 13.592.000 40.98%
2005 597.000 -2176.72%
2006 1.407.000 57.57%
2007 -2.064.000 168.17%
2008 22.146.000 109.32%
2009 -7.348.000 401.39%
2010 7.914.000 192.85%
2011 2.480.000 -219.11%
2012 -134.000 1950.75%
2013 -611.000 78.07%
2014 -1.584.000 61.43%
2015 3.548.000 144.64%
2016 3.763.000 5.71%
2017 6.476.000 41.89%
2018 6.555.000 1.21%
2019 7.368.000 11.03%
2020 4.108.000 -79.36%
2021 35.000 -11637.14%
2022 129.000 72.87%
2023 13.288.000 99.03%
2023 13.386.000 0.73%
2024 19.732.000 32.16%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Ultralife Corporation Gross Profit
Year Gross Profit Growth
1992 -300.000
1993 1.000.000 130%
1994 700.000 -42.86%
1995 2.400.000 70.83%
1996 2.600.000 7.69%
1997 2.100.000 -23.81%
1998 3.300.000 36.36%
1999 4.300.000 23.26%
2000 1.040.000 -313.46%
2001 -3.533.000 129.44%
2002 1.347.000 362.29%
2003 17.096.000 92.12%
2004 20.302.000 15.79%
2005 12.258.000 -65.62%
2006 17.443.000 29.73%
2007 28.774.000 39.38%
2008 56.943.000 49.47%
2009 36.860.000 -54.48%
2010 46.569.000 20.85%
2011 35.393.000 -31.58%
2012 28.730.000 -23.19%
2013 22.621.000 -27.01%
2014 19.350.000 -16.9%
2015 23.316.000 17.01%
2016 25.108.000 7.14%
2017 26.232.000 4.28%
2018 25.583.000 -2.54%
2019 31.165.000 17.91%
2020 29.159.000 -6.88%
2021 24.642.000 -18.33%
2022 29.400.000 16.18%
2023 39.096.000 24.8%
2023 38.311.000 -2.05%
2024 45.344.000 15.51%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Ultralife Corporation Net Profit
Year Net Profit Growth
1992 -1.700.000
1993 -800.000 -112.5%
1994 -3.100.000 74.19%
1995 -3.400.000 8.82%
1996 -3.200.000 -6.25%
1997 -7.200.000 55.56%
1998 -7.000.000 -2.86%
1999 -7.100.000 1.41%
2000 -10.242.000 30.68%
2001 -17.262.000 40.67%
2002 -25.182.000 31.45%
2003 6.447.000 490.6%
2004 22.332.000 71.13%
2005 -4.345.000 613.97%
2006 -27.488.000 84.19%
2007 5.583.000 592.35%
2008 13.663.000 59.14%
2009 -9.241.000 247.85%
2010 -6.179.000 -49.55%
2011 -2.080.000 -197.07%
2012 -1.598.000 -30.16%
2013 -926.000 -72.57%
2014 -2.116.000 56.24%
2015 2.869.000 173.75%
2016 3.509.000 18.24%
2017 7.648.000 54.12%
2018 24.930.000 69.32%
2019 5.205.000 -378.96%
2020 5.232.000 0.52%
2021 -230.000 2374.78%
2022 -120.000 -91.67%
2023 5.320.000 102.26%
2023 7.197.000 26.08%
2024 11.876.000 39.4%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Ultralife Corporation Earning per Share (EPS)
Year Earning per Share (EPS) Growth
1992 -1
1993 0 0%
1994 -1 0%
1995 -1 0%
1996 0 0%
1997 -1 0%
1998 -1 0%
1999 -1 0%
2000 -1 0%
2001 -2 100%
2002 -2 50%
2003 0 0%
2004 2 100%
2005 0 0%
2006 -2 100%
2007 0 0%
2008 1 0%
2009 -1 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 2 100%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2023 0 0%
2024 1 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Ultralife Corporation Free Cashflow
Year Free Cashflow Growth
1992 -1.700.000
1993 -1.800.000 5.56%
1994 -3.000.000 40%
1995 -8.900.000 66.29%
1996 -13.400.000 33.58%
1997 -10.500.000 -27.62%
1998 -14.900.000 29.53%
1999 -11.400.000 -30.7%
2000 -13.478.000 15.42%
2001 -14.037.000 3.98%
2002 -10.529.000 -33.32%
2003 -10.127.000 -3.97%
2004 5.438.000 286.23%
2005 -8.896.000 161.13%
2006 -1.304.000 -582.21%
2007 -504.000 -158.73%
2008 15.271.000 103.3%
2009 -3.000 509133.33%
2010 9.094.000 100.03%
2011 8.600.000 -5.74%
2012 2.083.000 -312.87%
2013 6.131.000 66.03%
2014 2.012.000 -204.72%
2015 5.641.000 64.33%
2016 6.434.000 12.33%
2017 5.878.000 -9.46%
2018 6.701.000 12.28%
2019 -9.251.000 172.44%
2020 18.619.000 149.69%
2021 1.511.000 -1132.23%
2022 -2.942.000 151.36%
2023 -623.000 -372.23%
2023 -1.423.000 56.22%
2024 8.565.000 116.61%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Ultralife Corporation Operating Cashflow
Year Operating Cashflow Growth
1992 -1.500.000
1993 -1.600.000 6.25%
1994 -2.200.000 27.27%
1995 -7.000.000 68.57%
1996 -6.700.000 -4.48%
1997 -1.600.000 -318.75%
1998 -2.700.000 40.74%
1999 -8.000.000 66.25%
2000 -10.532.000 24.04%
2001 -9.670.000 -8.91%
2002 -8.199.000 -17.94%
2003 -4.567.000 -79.53%
2004 10.875.000 142%
2005 -5.587.000 294.65%
2006 151.000 3800%
2007 1.569.000 90.38%
2008 19.058.000 91.77%
2009 2.032.000 -837.89%
2010 10.909.000 81.37%
2011 10.962.000 0.48%
2012 4.768.000 -129.91%
2013 6.897.000 30.87%
2014 3.665.000 -88.19%
2015 8.551.000 57.14%
2016 7.653.000 -11.73%
2017 7.270.000 -5.27%
2018 10.886.000 33.22%
2019 -2.970.000 466.53%
2020 21.720.000 113.67%
2021 4.325.000 -402.2%
2022 -1.263.000 442.44%
2023 1.929.000 165.47%
2023 -889.000 316.99%
2024 8.925.000 109.96%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Ultralife Corporation Capital Expenditure
Year Capital Expenditure Growth
1992 200.000
1993 200.000 0%
1994 800.000 75%
1995 1.900.000 57.89%
1996 6.700.000 71.64%
1997 8.900.000 24.72%
1998 12.200.000 27.05%
1999 3.400.000 -258.82%
2000 2.946.000 -15.41%
2001 4.367.000 32.54%
2002 2.330.000 -87.42%
2003 5.560.000 58.09%
2004 5.437.000 -2.26%
2005 3.309.000 -64.31%
2006 1.455.000 -127.42%
2007 2.073.000 29.81%
2008 3.787.000 45.26%
2009 2.035.000 -86.09%
2010 1.815.000 -12.12%
2011 2.362.000 23.16%
2012 2.685.000 12.03%
2013 766.000 -250.52%
2014 1.653.000 53.66%
2015 2.910.000 43.2%
2016 1.219.000 -138.72%
2017 1.392.000 12.43%
2018 4.185.000 66.74%
2019 6.281.000 33.37%
2020 3.101.000 -102.55%
2021 2.814.000 -10.2%
2022 1.679.000 -67.6%
2023 2.552.000 34.21%
2023 534.000 -377.9%
2024 360.000 -48.33%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Ultralife Corporation Equity
Year Equity Growth
1992 4.700.000
1993 27.100.000 82.66%
1994 27.600.000 1.81%
1995 58.000.000 52.41%
1996 56.400.000 -2.84%
1997 46.800.000 -20.51%
1998 68.500.000 31.68%
1999 60.400.000 -13.41%
2000 54.477.000 -10.87%
2001 37.453.000 -45.45%
2002 21.164.000 -76.97%
2003 34.430.000 38.53%
2004 63.625.000 45.89%
2005 62.107.000 -2.44%
2006 39.589.000 -56.88%
2007 63.007.000 37.17%
2008 88.153.000 28.53%
2009 78.114.000 -12.85%
2010 73.795.000 -5.85%
2011 73.226.000 -0.78%
2012 73.451.000 0.31%
2013 73.645.000 0.26%
2014 71.913.000 -2.41%
2015 66.060.000 -8.86%
2016 67.860.000 2.65%
2017 79.049.000 14.15%
2018 104.534.000 24.38%
2019 109.750.000 4.75%
2020 116.923.000 6.13%
2021 117.743.000 0.7%
2022 116.403.000 -1.15%
2023 121.758.000 4.4%
2023 125.427.000 2.93%
2024 133.345.000 5.94%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Ultralife Corporation Assets
Year Assets Growth
1992 7.400.000
1993 30.200.000 75.5%
1994 30.100.000 -0.33%
1995 62.600.000 51.92%
1996 60.600.000 -3.3%
1997 51.400.000 -17.9%
1998 75.800.000 32.19%
1999 66.500.000 -13.98%
2000 64.460.000 -3.16%
2001 47.203.000 -36.56%
2002 30.063.000 -57.01%
2003 52.352.000 42.58%
2004 81.134.000 35.47%
2005 80.757.000 -0.47%
2006 97.758.000 17.39%
2007 122.048.000 19.9%
2008 129.587.000 5.82%
2009 131.166.000 1.2%
2010 114.835.000 -14.22%
2011 100.815.000 -13.91%
2012 97.718.000 -3.17%
2013 90.216.000 -8.32%
2014 87.622.000 -2.96%
2015 81.571.000 -7.42%
2016 84.744.000 3.74%
2017 97.186.000 12.8%
2018 120.104.000 19.08%
2019 144.557.000 16.92%
2020 137.701.000 -4.98%
2021 159.050.000 13.42%
2022 168.430.000 5.57%
2023 176.109.000 4.36%
2023 178.276.000 1.22%
2024 169.817.000 -4.98%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Ultralife Corporation Liabilities
Year Liabilities Growth
1992 2.700.000
1993 3.100.000 12.9%
1994 2.500.000 -24%
1995 4.600.000 45.65%
1996 4.200.000 -9.52%
1997 4.600.000 8.7%
1998 7.300.000 36.99%
1999 6.100.000 -19.67%
2000 9.983.000 38.9%
2001 9.750.000 -2.39%
2002 8.899.000 -9.56%
2003 17.922.000 50.35%
2004 17.509.000 -2.36%
2005 18.650.000 6.12%
2006 58.169.000 67.94%
2007 59.041.000 1.48%
2008 41.434.000 -42.49%
2009 53.052.000 21.9%
2010 41.040.000 -29.27%
2011 27.589.000 -48.75%
2012 24.267.000 -13.69%
2013 16.571.000 -46.44%
2014 15.709.000 -5.49%
2015 15.511.000 -1.28%
2016 16.884.000 8.13%
2017 18.137.000 6.91%
2018 15.570.000 -16.49%
2019 34.807.000 55.27%
2020 20.778.000 -67.52%
2021 41.307.000 49.7%
2022 52.027.000 20.6%
2023 54.351.000 4.28%
2023 52.849.000 -2.84%
2024 36.472.000 -44.9%

Ultralife Corporation Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
10.2
Net Income per Share
0.61
Price to Earning Ratio
15.06x
Price To Sales Ratio
0.9x
POCF Ratio
14.59
PFCF Ratio
18.74
Price to Book Ratio
1.14
EV to Sales
0.96
EV Over EBITDA
9.03
EV to Operating CashFlow
15.57
EV to FreeCashFlow
19.92
Earnings Yield
0.07
FreeCashFlow Yield
0.05
Market Cap
0,15 Bil.
Enterprise Value
0,16 Bil.
Graham Number
10.48
Graham NetNet
0.86

Income Statement Metrics

Net Income per Share
0.61
Income Quality
1.03
ROE
0.08
Return On Assets
0.05
Return On Capital Employed
0.08
Net Income per EBT
0.82
EBT Per Ebit
0.9
Ebit per Revenue
0.07
Effective Tax Rate
0.17

Margins

Sales, General, & Administrative to Revenue
0
Research & Developement to Revenue
0.04
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.26
Operating Profit Margin
0.07
Pretax Profit Margin
0.07
Net Profit Margin
0.05

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
0.63
Free CashFlow per Share
0.49
Capex to Operating CashFlow
0.22
Capex to Revenue
0.01
Capex to Depreciation
0.58
Return on Invested Capital
0.08
Return on Tangible Assets
0.09
Days Sales Outstanding
67.09
Days Payables Outstanding
28.25
Days of Inventory on Hand
120.68
Receivables Turnover
5.44
Payables Turnover
12.92
Inventory Turnover
3.02
Capex per Share
0.14

Balance Sheet

Cash per Share
0,40
Book Value per Share
8,05
Tangible Book Value per Share
4.9
Shareholders Equity per Share
8.04
Interest Debt per Share
0.91
Debt to Equity
0.1
Debt to Assets
0.08
Net Debt to EBITDA
0.54
Current Ratio
4.07
Tangible Asset Value
0,08 Bil.
Net Current Asset Value
0,05 Bil.
Invested Capital
139976000
Working Capital
0,06 Bil.
Intangibles to Total Assets
0.31
Average Receivables
0,03 Bil.
Average Payables
0,01 Bil.
Average Inventory
42606500
Debt to Market Cap
0.09

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Ultralife Corporation Dividends
Year Dividends Growth

Ultralife Corporation Profile

About Ultralife Corporation

Ultralife Corporation, together with its subsidiaries, designs, manufactures, installs, and maintains power, and communication and electronics systems worldwide. The company operates in two segments, Battery & Energy Products and Communications Systems. The Battery & Energy Products segment offers lithium 9-volt, cylindrical, thin lithium manganese dioxide, rechargeable, and other non-rechargeable batteries; lithium-ion cells, multi-kilowatt module lithium ion battery systems, and uninterruptable power supplies; and rugged military and commercial battery charging systems and accessories, including smart chargers, multi-bay charging systems, and various cables. The Communications Systems segment provides communications systems and accessories to support military communications systems, such as radio frequency amplifiers, power supplies and cables, connector assemblies, amplified speakers, equipment mounts, case equipment, man-portable systems, and integrated communication systems for fixed or vehicle applications comprising vehicle adapters, vehicle installed power enhanced rifleman appliqué systems, and SATCOM systems. This segment's military communications systems and accessories are designed to enhance and extend the operation of communications equipment, such as vehicle-mounted, manpack, and handheld transceivers. It sells its products under the Ultralife, Ultralife Thin Cell, Utralife HiRate, Ultralife and design, Ultra, Lithium Power, LithiumPower and Design, McDowell Research, AMTI, ABLE, ACCUTRONICS, ACCUPRO, ENTELLION, SWE Southwest Electronic Energy Group, SWE DRILL-DATA, and SWE SEASAFE brands through original equipment manufacturers, and industrial and defense supply distributors, as well as directly to the United States and international defense departments. In addition, the company sells its 9-volt battery to the broader consumer market through national and regional retail chains and online retailers. Ultralife Corporation serves government, defense, and commercial sectors. The company was incorporated in 1990 and is headquartered in Newark, New York.

CEO
Mr. Michael E. Manna
Employee
536
Address
2000 Technology Parkway
Newark, 14513

Ultralife Corporation Executives & BODs

Ultralife Corporation Executives & BODs
# Name Age
1 Mr. Philip A. Fain CPA
Chief Financial Officer, Treasurer & Corporate Secretary
70
2 Mr. James J. Rasmussen
President of Communication System
70
3 Mr. Michael E. Manna
President, Chief Executive Officer & Director
70

Ultralife Corporation Competitors